SRPL — Shreeram Proteins Income Statement
0.000.00%
Last trade - 00:00- IN₹227.05m
- IN₹608.28m
Annual income statement for Shreeram Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,526 | 2,878 | 1,627 | 148 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 111 | 179 | 146 | -45.6 | -186 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,478 | 2,758 | 1,532 | 238 | 202 |
| Operating Profit | 47.5 | 120 | 95.3 | -90.3 | -202 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 11 | 82.4 | 52.8 | -101 | -210 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 8.37 | 61.4 | 38.5 | -95.8 | -211 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 8.37 | 61.4 | 38.5 | -95.8 | -211 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 8.37 | 61.4 | 38.5 | -95.8 | -211 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.033 | 0.239 | 0.15 | -0.45 | -0.98 |